These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7399848)

  • 1. Experiments with radiopaque perfluorocarbon emulsions for selective opacification of organs and total body angiography.
    Long DM; Lasser EC; Sharts CM; Multer FK; Nielsen M
    Invest Radiol; 1980; 15(3):242-7. PubMed ID: 7399848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon.
    Wolber J; Rowland IJ; Leach MO; Bifone A
    Magn Reson Med; 1999 Mar; 41(3):442-9. PubMed ID: 10204864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations.
    Young SW; Enzmann DR; Long DM; Muller HH
    AJR Am J Roentgenol; 1981 Jul; 137(1):141-6. PubMed ID: 6787865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor imaging with x-rays using macrophage uptake of radiopaque fluorocarbon emulsions.
    Long DM; Multer FK; Greenburg AG; Peskin GW; Lasser EC; Wickham WG; Sharts CM
    Surgery; 1978 Jul; 84(1):104-12. PubMed ID: 208188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between a perfluorocarbon emulsion and radiographic contrast media.
    Franke RP; Reuter P; Röhlke W; Matschke K; Keller S; Klosterhalfen B; Mittermayer C; Mrowietz C; Jung F
    J Invasive Cardiol; 2004 Mar; 16(3):110-2. PubMed ID: 15152157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
    Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
    Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An emulsion based on 1-bromoperfluorooctane: X-ray contrast properties and mechanisms of X-ray contrasting].
    Sklifas AN; Chaplygina SL; Shekhtman DG; Kukushkin NI
    Biofizika; 2007; 52(2):367-71. PubMed ID: 17477068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-tumor imaging using radiopaque perfluorocarbon. A preliminary report.
    Patronas NJ; Hekmatpanah J; Doi K
    J Neurosurg; 1983 May; 58(5):650-3. PubMed ID: 6834111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle size distribution of concentrated perfluorocarbon emulsions by sedimentation field flow fractionation.
    Klein DH; Burtner DB; Trevino LA; Arlauskas RA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):859-64. PubMed ID: 1391524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorocarbon emulsions cytotoxic effects on human fibroblasts and effect of aging on particle size distribution.
    Centis V; Doillon CJ; Vermette P
    Artif Organs; 2007 Aug; 31(8):649-53. PubMed ID: 17651121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.
    Noveck RJ; Shannon EJ; Leese PT; Shorr JS; Flaim KE; Keipert PE; Woods CM
    Anesth Analg; 2000 Oct; 91(4):812-22. PubMed ID: 11004031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous hepatosplenography. Experiment evaluation of a new contrast material.
    Vermess M; Adamson RH; Doppman JL; Rabson AS; Herdt JR
    Radiology; 1976 Apr; 119(1):31-7. PubMed ID: 815953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of perfluorocarbon emulsions in cell culture.
    Ju LK; Armiger WB
    Biotechniques; 1992 Feb; 12(2):258-63. PubMed ID: 1616720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable perfluorocarbon emulsions for the delivery of halogenated ether anesthetics.
    Ashrafi B; Tootoonchi MH; Bardsley R; Molano RD; Ruiz P; Pretto EA; Fraker CA
    Colloids Surf B Biointerfaces; 2018 Dec; 172():797-805. PubMed ID: 30342412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of the fate of injections of water-in-oil emulsions by means of radiopaque media, II.
    BROWN EA; METCALF TG; SLANETZ LW
    Ann Allergy; 1961 Sep; 19():1016-8. PubMed ID: 13873617
    [No Abstract]   [Full Text] [Related]  

  • 18. Uptake of concentrated perfluorocarbon emulsions into rat lymphoid tissues.
    Bentley PK; Johnson OL; Washington C; Lowe KC
    J Pharm Pharmacol; 1993 Mar; 45(3):182-5. PubMed ID: 8097775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arthrography using perfluorocarbon compounds.
    Enzmann DR; Young S
    Invest Radiol; 1981; 16(1):46-9. PubMed ID: 7012088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The electroencephalographic effects of GABA when using perfluorocarbon emulsions in rats].
    Vorob'ev VV; Gorelkova TF; Kukushkin NI; Kosarskiĭ LS
    Eksp Klin Farmakol; 1994; 57(4):11-3. PubMed ID: 7950771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.